European Union
International Standa...
NGOs
United Nations
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua & Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean...
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burma (Myanmar)
Burundi
Cambodia
Cameroon
Canada
Cape Verde Islands
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo (Brazzaville)
Congo, Democratic Re...
Cook Islands
Costa Rica
Cote d'Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Terr...
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Hawai
Heard and McDonald I...
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Marianas Islands
Norway
Oman
Pakistan
Palau
Palestinian Authority
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Samoa
San Marino
Sao Tome & Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia
South Korea
Spain
Sri Lanka
St-Barthelemy
St-Martin
St. Helena
St. Kitts & Nevis
St. Lucia
St. Pierre et Miquelon
St. Vincent & the Gr...
Sudan
Suriname
Svalbard & Jan Mayen...
Swaziland
Sweden
Switzerland
Syria
Taiwan (Republic of ...
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad & Tobago
Tunisia
Turkey
Turkmenistan
Turks & Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States (Minor...
United States of America
Uruguay
US Virgin Islands
Uzbekistan
Vanuatu
Vatican City State (...
Venezuela
Vietnam
Wallis & Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe
|
Institute for Occupational Medicine (IOM)
| Report Title: |
EMERGNANO: a Review of Completed and Near Completed Environment, Health and Safety Research on Nanomaterials and Nanotechnology |
| Report ID: |
466 |
| Date: |
3/1/2009 |
| Author: |
RJ Aitken, SM Hankin, B Ross, et al |
| Report Type: |
Research Report |
| URL: |
[Document.aspx] |
| Country: |
United Kingdom |
| Organization: |
Institute for Occupational Medicine (IOM) |
| Summary: |
After the Royal Society and Royal Academy of Engineering's 2004 report (see report ID 446) on opportunities and uncertainties in nanotechnology, the UK set up the Nanotechnology Research Coordination Group to coordinate publicly funded research into the risks of nanotechnology. Under the guidance of Defra, this report was commissioned to review and analyze the state of research in 18 research objectives set out in Defra's 2006 first research progress report. This report also assesses the possibility of a qualitative risk assessment and makes recommendations for new research to fill gaps. Research studies were categorized by their relation to one or more of the research objectives. The study finds that there is a widespread imbalance in the work carried out between the research objectives. While 44 studies were relevant to RO14 (Research Objective 14 – research to establish a clear understanding of the deposition, distribution, toxicity, pathogenicity, and translocation potential and pathways for nanoparticles in the airways and lung and their potential impacts on the cardiovascular system and brain), only one study was relevant to RO9 (optimization, development, and application of technologies that enable the measurement of exposure to nanoparticles in soil and water). Many of the studies, although publicly funded, had not released any information into the public domain. A total of 260 relevant studies worldwide were identified in this report, and analysis so far shows that three nanomaterials are cause for concern: carbon nanotubes, silver nanoparticles, and titanium dioxide nanoparticles. |
| Archived Copy: |
CB0409_7911_FRP_466_1948.pdf |
 |
|
| Report Title: |
An Outline Scoping Study to Determine Whether High Aspect Ratio Nanoparticles (harn) Should Raise the Same Concerns as Do Asbestos Fibres |
| Report ID: |
182 |
| Date: |
8/13/2008 |
| Author: |
CL Tran, SM Hankin, B Ross, RJ Aitken, AD Jones, |
| Report Type: |
Research Report |
| URL: |
[Document.aspx] |
| Country: |
United Kingdom |
| Organization: |
Institute for Occupational Medicine (IOM) |
| Summary: |
The similar size and shape of certain nanoparticles, particularly carbon nanotubes, to asbestos fibers has created significant concern because of the well-publicized risks of asbestos towards human health. This study seeks to review existing literature on whether high aspect ratio nanoparticles (HARN) should generate the same concerns as do asbestos fibers. It also establishes a research strategy for the determination of specific health risks posed by HARN. Three fiber characteristics are likely to cause asbestos-like injuries: diameter, length, and biopersistence. The review concludes that HARN are similar enough in these characteristics as to pose similar health risks. The proposed strategy for examining these risks is composed of stages of hazard identification, dose-response assessment, exposure assessment, and risk assessment. The report makes a list of prioritized recommendations for further studies, both in vivo and in vitro, of these areas. |
| Archived Copy: |
Michael Vincent IOM (2008), An outline scoping study_182_2184.pdf |
|
|
|